Skip to main content
Erschienen in: Zeitschrift für Gerontologie und Geriatrie 1/2013

01.01.2013 | CME Zertifizierte Fortbildung

Diastolische Herzinsuffizienz

Herzinsuffizienz mit erhaltener Linksventrikelfunktion

verfasst von: Prim. Dr. P. Dovjak

Erschienen in: Zeitschrift für Gerontologie und Geriatrie | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Prognose von Patienten mit diastolischer Herzinsuffizienz – Herzinsuffizienz mit erhaltener Linksventrikelfunktion – blieb in den letzten Dekaden gleich schlecht, obwohl die Prognose bei der Gesamtheit der Patienten mit Herzinsuffizienz besser wurde. Eine diastolische Dysfunktion wird bei älteren Patienten mit Herzinsuffizienz häufig diagnostiziert. Die Diagnostik stellt für die Kliniker aufgrund der Begleiterkrankungen wie chronische Atemwegserkrankung, Polyarthrosen, Sarkopenie oder Diabetes eine Herausforderung dar. Klassische Behandlungsempfehlungen versagen bei der diastolischen Herzinsuffizienz, ein umfassender und spezifischer Behandlungsplan ist daher nötig.
Literatur
1.
2.
Zurück zum Zitat Ahmed A, Rich MW, Fleg JL (2006) Effects of digoxin on morbidity and mortality in diastolic heart failure. Circulation 114:397–403PubMedCrossRef Ahmed A, Rich MW, Fleg JL (2006) Effects of digoxin on morbidity and mortality in diastolic heart failure. Circulation 114:397–403PubMedCrossRef
3.
4.
Zurück zum Zitat Bhatia RS, Tu JV, Lee DS et al (2006) Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355:260–269PubMedCrossRef Bhatia RS, Tu JV, Lee DS et al (2006) Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355:260–269PubMedCrossRef
5.
Zurück zum Zitat Böhm M, Voors AA, Ketelslegers JM et al (2011) Biomarkers: optimizing treatment guidance in heart failure. Clin Res Cardiol 100:973–981PubMedCrossRef Böhm M, Voors AA, Ketelslegers JM et al (2011) Biomarkers: optimizing treatment guidance in heart failure. Clin Res Cardiol 100:973–981PubMedCrossRef
6.
Zurück zum Zitat Brandt MC, Mahfoud F, Reda S et al (2012) Renal sympathic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol 59:901–909PubMedCrossRef Brandt MC, Mahfoud F, Reda S et al (2012) Renal sympathic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol 59:901–909PubMedCrossRef
7.
Zurück zum Zitat Brandt MC, Madershahian N, Velden R et al (2011) Baroreflex activation as a novel therapeutic strategy for diastolic heart failure. Clin Res Cardiol 100:249–251PubMedCrossRef Brandt MC, Madershahian N, Velden R et al (2011) Baroreflex activation as a novel therapeutic strategy for diastolic heart failure. Clin Res Cardiol 100:249–251PubMedCrossRef
8.
Zurück zum Zitat Cha Y-M, Wokhlu A, Asirvatham SJ et al (2011) Success of ablation for atrial fibrillation in isolated left ventricular diastolic dysfunction. Circ Arrhythm Electrophysiol 4:724–732PubMedCrossRef Cha Y-M, Wokhlu A, Asirvatham SJ et al (2011) Success of ablation for atrial fibrillation in isolated left ventricular diastolic dysfunction. Circ Arrhythm Electrophysiol 4:724–732PubMedCrossRef
9.
Zurück zum Zitat Chinnaiyan KM, Alexander D, Maddens M et al (2007) Curriculum in cardiology: integrated diagnosis and management of diastolic heart failure. Am Heart J 153:189–200PubMedCrossRef Chinnaiyan KM, Alexander D, Maddens M et al (2007) Curriculum in cardiology: integrated diagnosis and management of diastolic heart failure. Am Heart J 153:189–200PubMedCrossRef
10.
Zurück zum Zitat Cleland JGF, Tendera M, Adamus J et al (2006) The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 27:2338–2345PubMedCrossRef Cleland JGF, Tendera M, Adamus J et al (2006) The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 27:2338–2345PubMedCrossRef
11.
Zurück zum Zitat Conraads VM, Metra M, Kamp O et al (2012) Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction; results of the ELANDD study. Eur Heart J 14:219–225CrossRef Conraads VM, Metra M, Kamp O et al (2012) Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction; results of the ELANDD study. Eur Heart J 14:219–225CrossRef
12.
Zurück zum Zitat Desai AS, Lewis EF, Li R et al (2011) Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction. Am Heart J 162:966–973PubMedCrossRef Desai AS, Lewis EF, Li R et al (2011) Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction. Am Heart J 162:966–973PubMedCrossRef
13.
Zurück zum Zitat Dickstein K, Cohne-Solal A, Filippatos G et al (2008) ESC Guidelines for the diagnosis and treatment of actue and chronic heart failure 2008. Eur Heart J 29:2388–2442PubMedCrossRef Dickstein K, Cohne-Solal A, Filippatos G et al (2008) ESC Guidelines for the diagnosis and treatment of actue and chronic heart failure 2008. Eur Heart J 29:2388–2442PubMedCrossRef
14.
Zurück zum Zitat Flather MD, Shibata MC, Coats AJS et al (2005) Randomized trial to determine the effect of nibivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 26:215–225PubMedCrossRef Flather MD, Shibata MC, Coats AJS et al (2005) Randomized trial to determine the effect of nibivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 26:215–225PubMedCrossRef
16.
Zurück zum Zitat Hayley BD, Burwash IG (2012) Heart failure with normal left ventricular ejection fraction: role of echocardiography Curr Opin Cardiol 27:169–180 Hayley BD, Burwash IG (2012) Heart failure with normal left ventricular ejection fraction: role of echocardiography Curr Opin Cardiol 27:169–180
18.
Zurück zum Zitat Mak GJ, Ledwidge MT, Watson CJ et al (2009) Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenon. J Am Coll Cardiol 54:1674–1682PubMedCrossRef Mak GJ, Ledwidge MT, Watson CJ et al (2009) Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenon. J Am Coll Cardiol 54:1674–1682PubMedCrossRef
19.
Zurück zum Zitat Marengoini A, Rizzuto D, Harding SE et al (2009) Patterns of chronic multimorbidity in the elderly population. J Am Geriatr Soc 57:225–230CrossRef Marengoini A, Rizzuto D, Harding SE et al (2009) Patterns of chronic multimorbidity in the elderly population. J Am Geriatr Soc 57:225–230CrossRef
20.
Zurück zum Zitat Massie BM, Carson PE, McMurray JJ et al (2008) Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 359:2456–2467PubMedCrossRef Massie BM, Carson PE, McMurray JJ et al (2008) Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 359:2456–2467PubMedCrossRef
21.
Zurück zum Zitat Maxwell CM, Jenkins AT (2011) Drug induced heart failure. Am J Health Syst Pharm 68:1791–1804PubMedCrossRef Maxwell CM, Jenkins AT (2011) Drug induced heart failure. Am J Health Syst Pharm 68:1791–1804PubMedCrossRef
22.
Zurück zum Zitat Nagueh SF, Appleton CP, Gillebert TC et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 10:165–193PubMedCrossRef Nagueh SF, Appleton CP, Gillebert TC et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 10:165–193PubMedCrossRef
23.
24.
Zurück zum Zitat Nguyen VTQ, Ho JE, Ho CY et al (2008) Handheld echocardiography offers rapid assessment of clinical volume status. Am Heart J 156:537–542PubMedCrossRef Nguyen VTQ, Ho JE, Ho CY et al (2008) Handheld echocardiography offers rapid assessment of clinical volume status. Am Heart J 156:537–542PubMedCrossRef
25.
Zurück zum Zitat Oghlakian GO, Sipahi I, Fang JC (2011) Treatment of heart failure with preserved ejection fraction. Have we been pursuing the wrong paradigm? Mayo Clin Proc 86:531–539PubMedCrossRef Oghlakian GO, Sipahi I, Fang JC (2011) Treatment of heart failure with preserved ejection fraction. Have we been pursuing the wrong paradigm? Mayo Clin Proc 86:531–539PubMedCrossRef
26.
Zurück zum Zitat Owan TE, Hodge DO, Herges RM et al (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355:251–259PubMedCrossRef Owan TE, Hodge DO, Herges RM et al (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355:251–259PubMedCrossRef
27.
Zurück zum Zitat Saczynski JS, Darling CE, Spencer FA et al (2009) Clinical features, treatment practices, and hospital and long-term outcomes of older patients hospitalized with decompensated heart failure: The Worcester Heart Failure Study. J Am Geriatr Soc 57:1587–1594PubMedCrossRef Saczynski JS, Darling CE, Spencer FA et al (2009) Clinical features, treatment practices, and hospital and long-term outcomes of older patients hospitalized with decompensated heart failure: The Worcester Heart Failure Study. J Am Geriatr Soc 57:1587–1594PubMedCrossRef
28.
Zurück zum Zitat Solomon SD, Janardhanan R, Verma A et al (2007) Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trail. Lancet 369:2079–2087PubMedCrossRef Solomon SD, Janardhanan R, Verma A et al (2007) Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trail. Lancet 369:2079–2087PubMedCrossRef
29.
Zurück zum Zitat Tzanetos K, Leong D, Wu RC (2009) Office management of patients with diastolic heart failure. CMAJ 180:520–527PubMedCrossRef Tzanetos K, Leong D, Wu RC (2009) Office management of patients with diastolic heart failure. CMAJ 180:520–527PubMedCrossRef
30.
Zurück zum Zitat Vasan RS, Levy D (2000) Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 101:2118–2121PubMedCrossRef Vasan RS, Levy D (2000) Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 101:2118–2121PubMedCrossRef
31.
Zurück zum Zitat Wei T, Zeng C, Chen L et al (2005) Systolic and diastolic heart failure are associated with different plasma levels of B-type natriuretic peptide. Int J Clin Pract 59:891–894PubMedCrossRef Wei T, Zeng C, Chen L et al (2005) Systolic and diastolic heart failure are associated with different plasma levels of B-type natriuretic peptide. Int J Clin Pract 59:891–894PubMedCrossRef
32.
Zurück zum Zitat Yusuf S, Pfeffer MA, Swedberg K (2003) Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362:777–781PubMedCrossRef Yusuf S, Pfeffer MA, Swedberg K (2003) Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362:777–781PubMedCrossRef
33.
Zurück zum Zitat Zile MR, Brutsaert DL (2002) New concept in diastolic dysfunction and diastolic heart failure. Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 105:1387–1393PubMedCrossRef Zile MR, Brutsaert DL (2002) New concept in diastolic dysfunction and diastolic heart failure. Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 105:1387–1393PubMedCrossRef
34.
Zurück zum Zitat Zile MR, Gaasch WH, Anand IS et al (2010) Mode of death in patients with heart failure and a preserved ejection fraction. Circulation 121:1393–1405PubMedCrossRef Zile MR, Gaasch WH, Anand IS et al (2010) Mode of death in patients with heart failure and a preserved ejection fraction. Circulation 121:1393–1405PubMedCrossRef
Metadaten
Titel
Diastolische Herzinsuffizienz
Herzinsuffizienz mit erhaltener Linksventrikelfunktion
verfasst von
Prim. Dr. P. Dovjak
Publikationsdatum
01.01.2013
Verlag
Springer-Verlag
Erschienen in
Zeitschrift für Gerontologie und Geriatrie / Ausgabe 1/2013
Print ISSN: 0948-6704
Elektronische ISSN: 1435-1269
DOI
https://doi.org/10.1007/s00391-012-0345-z

Weitere Artikel der Ausgabe 1/2013

Zeitschrift für Gerontologie und Geriatrie 1/2013 Zur Ausgabe

Mitteilungen der DGGG

Mitteilungen der DGGG

Beiträge zum Themenschwerpunkt

Hochaltrigkeit als Akzeptanzproblem